Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Aurinia Pharmaceuticals Inc., commonly referred to as Aurinia, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Canada. Founded in 2013, the company has rapidly established itself as a pioneer in developing innovative therapies for autoimmune diseases, particularly focusing on lupus nephritis.
With a strong operational presence across North America and Europe, Aurinia is renowned for its flagship product, LUPKYNIS™ (voclosporin), which offers a unique mechanism of action that enhances treatment options for patients. The company’s commitment to advancing patient care has positioned it as a notable contender in the biopharmaceutical market, achieving significant milestones in clinical development and regulatory approvals. Aurinia continues to drive innovation, aiming to improve the lives of those affected by chronic conditions.
-16 vs industry average
Aurinia’s score of 26 is lower than 38% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Aurinia Pharmaceuticals Inc., headquartered in CA within the Pharmaceutical Preparation Manufacturing industry, reported total emissions of 218,430 kg CO2e for 2023. In 2022, their Scope 2 emissions were 198,740 kg CO2e (location-based), with no Scope 1 emissions reported for that year. Aurinia does not currently have publicly disclosed reduction targets or a Climate Pledge.
No climate goals have been disclosed for Aurinia yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more